Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on: December 22,2023

Obesity is a risk factor for cardiotoxicity in chemotherapy-treated patients with breast cancer

byPublic Library of ScienceObesity is associated with a three-fold increased risk of cardiotoxicity in chemotherapy-treated patients with early-stage breast cancer, regardless of other predictor

Updated on:December 22,2023

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on: December 18,2023

Olaparib maintenance extends PFS by estimated three years in advanced ovarian cancer

byEuropean Society for Medical OncologyTwo-year maintenance therapy with olaparib, a PARP (poly ADP ribose polymerase) inhibitor, olaparib, led to a substantial, unprecedented improvement in pro

Updated on:December 18,2023

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe

Updated on: December 22,2023

How dangerous is it for lung cancer patients to skip radiation treatments?

by Cara MurezAs doctors work toward developing more personalized cancer care, a new study looks at whether lung cancer patients can miss a few days of radiation treatment and make them up with a highe

Updated on:December 22,2023

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, acco

Updated on: December 20,2023

Response to neoadjuvant chemo for breast cancer varies by sex

Both proportions and odds of pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) are numerically lower in men with breast cancer (BC) versus women with BC for each tumor subtype, acco

Updated on:December 20,2023

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on: February 01,2024

England moves to a single-dose HPV vaccine

by Cancer Research UKCredit: Cancer Research UKThe HPV vaccination program in England is moving to a single-dose schedule from September 2023, the UK Health Security Agency (UKHSA) has announced.

Updated on:February 01,2024

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la

Updated on: December 18,2023

Drugs for treating breast cancer in women are effective and well tolerated in men

byEuropean Society for Medical OncologyThere is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the la

Updated on:December 18,2023

How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

by Delthia Ricks , Medical XpressLymphoid BLaER1 cells undergo PANX1-dominant lysis. (A to C) BLaER1 cells were treated with topoisomerase poisons doxorubicin (2 μM) or etoposide (50 μM) for 24 hours.

Updated on: December 18,2023

How cancer cells die: Scientists explore new pathways of pyroptosis, killer kin of apoptosis

by Delthia Ricks , Medical XpressLymphoid BLaER1 cells undergo PANX1-dominant lysis. (A to C) BLaER1 cells were treated with topoisomerase poisons doxorubicin (2 μM) or etoposide (50 μM) for 24 hours.

Updated on:December 18,2023

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H

Updated on: December 22,2023

Study suggests new strategy for treating advanced, progressing bile duct cancer

byOhio State University Medical CenterCredit: Ohio State University Medical CenterA new study led by researchers at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer H

Updated on:December 22,2023

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Updated on: March 30,2024

BRCA Exchange aggregates data on thousands of BRCA variants to understand cancer risk

by National Cancer InstituteCredit: National Cancer InstituteA global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The B

Updated on:March 30,2024

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth

Updated on: December 23,2023

Five facts you may not know about brain tumors

by Laura Hegwer,Rush University Medical CenterCredit: Unsplash/CC0 Public DomainBrain tumors scare most people, but there are still reasons to be hopeful if you learn you have an abnormal growth

Updated on:December 23,2023

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on: December 19,2023

Detailed diagnosis boosts child cancer survival

byCancer Research UK| News6 March 2009More accurate disease classification now means some young children with neuroblastoma will have less intensive treatment with better survival, accordi

Updated on:December 19,2023

Scientists are one step closer to stopping drug-resistant tumors from growing

by Heather Simonsen, Huntsman Cancer InstituteBenjamin Myers, PhD in lab. Credit: Huntsman Cancer InstituteScientists have solved a long-standing mystery surrounding a cancer-promoting protein and how

Updated on: December 27,2023

Scientists are one step closer to stopping drug-resistant tumors from growing

by Heather Simonsen, Huntsman Cancer InstituteBenjamin Myers, PhD in lab. Credit: Huntsman Cancer InstituteScientists have solved a long-standing mystery surrounding a cancer-promoting protein and how

Updated on:December 27,2023